SCHEMBL522366

SCHEMBL522366

OCCN(CCO)C1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.37
CYP2D6 P10635 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.34
HSD17B10 Q99714 1/20 0.34
TSHR P16473 1/20 0.34
OPRM1 P35372 2/20 0.34
OPRD1 P41143 2/20 0.34
OPRK1 P41145 2/20 0.34
ADH1A P07327 2/20 0.32
ADH1C P00326 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
TYK2 P29597 1/20 0.32
SLC29A1 Q99808 2/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
ALDH1A1 P00352 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79285 0.97 LTA4H (0.39) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL6567107 0.97 LTA4H (0.39) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL3429371 0.97 OPRM1 (0.35) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL11787675 0.95 LTA4H (0.38) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL9320360 0.95 LTA4H (0.38) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL3426360 0.91 LTA4H (0.34) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL23736374 0.89 LTA4H (0.33) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL3430945 0.89 LTA4H (0.33) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL24951499 0.89 LTA4H (0.33) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10
SCHEMBL11209044 0.89 LTA4H (0.36) LTA4HCYP2D6CYP1A2CYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12558648-B2 Amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal apparatus KABUSHIKI KAISHA TOSHIBA (JP) 2026-02-24 US claimed
CN-119823071-A Preparation method of rifampicin spray Ding Celian 河北科技大学 2025-04-15 CN claimed
US-12128350-B2 Water-lean carbon dioxide absorbent and method for capturing carbon dioxide by using same CE-TEK CO., LTD. (KR) 2024-10-29 US claimed
US-20240042376-A1 WATER-LEAN CARBON DIOXIDE ABSORBENT AND METHOD FOR CAPTURING CARBON DIOXIDE BY USING SAME CE-TEK CO., LTD. (KR) 2024-02-08 US claimed
CN-117186032-A Preparation method of 1-amino-4-cyclopentyl piperazine and intermediate thereof 徐州博康信息化学品有限公司 2023-12-08 CN claimed
US-20230203067-A1 PRODUCTION PROCESS FOR AMINO ALCOHOLATES COVESTRO DEUTSCHLAND AG (DE) 2023-06-29 US claimed
WO-2023068516-A1 LOW-WATER TYPE CARBON DIOXIDE ABSORBENT AND METHOD FOR CAPTURING CARBON DIOXIDE BY USING SAME 주식회사 씨이텍 2023-04-27 WO claimed
EP-4161939-A1 PRODUCTION PROCESS FOR AMINO ALCOHOLATES Covestro Deutschland AG (DE) 2023-04-12 EP claimed
US-11090603-B2 Acidic gas absorbent, acidic gas removal method and acidic gas removal apparatus KABUSHIKI KAISHA TOSHIBA (JP) 2021-08-17 US claimed
US-12558648-B2 Amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal apparatus KABUSHIKI KAISHA TOSHIBA (JP) 2026-02-24 US disclosed
CN-119823071-A Preparation method of rifampicin spray Ding Celian 河北科技大学 2025-04-15 CN disclosed
CN-119823071-A Preparation method of rifampicin spray Ding Celian 河北科技大学 2025-04-15 CN disclosed
US-12128350-B2 Water-lean carbon dioxide absorbent and method for capturing carbon dioxide by using same CE-TEK CO., LTD. (KR) 2024-10-29 US disclosed
US-20240307817-A1 ACID GAS ABSORBENT, METHOD FOR REMOVING ACID GAS, AND ACID GAS REMOVAL APPARATUS KABUSHIKI KAISHA TOSHIBA (JP) 2024-09-19 US disclosed
US-20100256755-A1 Poly(Tetrafluoroethene) Polymer With Nitric Oxide Donating Surface MEDTRONIC VASCULAR, INC. (US) 2010-10-07 US disclosed
US-7691867-B2 Chemical compounds ASTRAZENECA AB (SE) 2010-04-06 US disclosed
EP-1613619-B1 QUINAZOLINE DERIVATIVES FOR TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-03-26 EP disclosed
US-20060270692-A1 Chemical compounds ASTRAZENECA AB (SE) 2006-11-30 US disclosed
EP-1613619-A1 QUINAZOLINE DERIVATIVES FOR TREATMENT OF CANCER AstraZeneca AB (SE) 2006-01-11 EP disclosed
WO-2004094410-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203067-A1 PRODUCTION PROCESS FOR AMINO ALCOHOLATES BCAT1, BCAT2, AADAT LTA4H 4300/4885CYP2D6 2156/4885CYP1A2 544/4885
US-20060270692-A1 Chemical compounds CCNI, MKI67, TP53 LTA4H 3097/4885CYP2D6 707/4885CYP1A2 266/4885
US-12558648-B2 Amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal apparatus ADRB2, ADRA1D, HRH2 LTA4H 1228/4885CYP2D6 784/4885CYP1A2 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.